Stocks and Investing Stocks and Investing
Fri, October 13, 2023
Thu, October 12, 2023

Joseph Pantginis Maintained (ATXS) at Strong Buy with Decreased Target to $18 on, Oct 12th, 2023


Published on 2024-10-28 06:52:17 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Maintained "Astria Therapeutics, Inc." (ATXS) at Strong Buy with Decreased Target from $20 to $18 on, Oct 12th, 2023.

Joseph has made no other calls on ATXS in the last 4 months.



There is 1 other peer that has a rating on ATXS. Out of the 1 peers that are also analyzing ATXS, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $25 on, Tuesday, August 8th, 2023
Contributing Sources